Cite

HARVARD Citation

    Sun, J. et al. (2018). Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C—can one size fit all?. Alimentary pharmacology & therapeutics. 47 (6), pp. 853-854. [Online]. 
  
Back to record